Gould Capital’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
Gould Capital's TAK Position: Q3 2026 in Review
Gould Capital held its Takeda Pharmaceutical (TAK) position steady in Q3 2026 at 70 shares worth $1.27K. The position accounts for ﹤0.01% of the portfolio, ranked #188.
Gould Capital first reported a position in TAK in Q4 2021 and has held it in 20 quarters since. The position peaked at $1.3K in Q1 2026. 400 funds tracked by Wall St. Rank hold TAK as of Q3 2026.
- Gould Capital held 70 shares of Takeda Pharmaceutical worth $1.27K as of Q3 2026.
- Gould Capital left its Takeda Pharmaceutical share count unchanged in Q3 2026.
- Takeda Pharmaceutical made up ﹤0.01% of Gould Capital's portfolio in Q3 2026, its #188 holding.
- Gould Capital first reported a position in Takeda Pharmaceutical in Q4 2021 and has held it in 20 quarters since.
- Gould Capital's Takeda Pharmaceutical position peaked at $1.3K in Q1 2026.
- 400 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.
Based on Gould Capital's 13F filing for Q3 2026, filed 13 Nov 2026.